title: Updating the British Society for Rheumatology guidelines for anti-tumour necrosis factor therapy in adult rheumatoid arthritis (again).
authors.forename: C M
authors.initials: CM
authors.lastname: Deighton
authors.forename: E
authors.initials: E
authors.lastname: George
authors.forename: P D W
authors.initials: PD
authors.lastname: Kiely
authors.forename: J
authors.initials: J
authors.lastname: Ledingham
authors.forename: R A
authors.initials: RA
authors.lastname: Luqmani
authors.forename: D G I
authors.initials: DG
authors.lastname: Scott
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006801:Humans; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D012219:Rheumatology / Q000592:standards*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D006113:United Kingdom
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha